Isofol appoints Magnus Hurst as new Chief Financial Officer
GOTHENBURG, Sweden, January 10, 2024 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the company has appointed Magnus Hurst as new Chief Financial Officer. He has broad financial experience and takes up the position with immediate effect.The information in the press release is intended for investors. Magnus Hurst has long experience in financial roles at companies such as SAS and within the Kinnevik Group. He currently holds a position as CFO and Head of Investor Relations at the biotech company Synartro and will combine this role with the new assignment as CFO